Ivosidenib and Azacitidine in IDH1-Mutated AML. Reply

Pau Montesinos, Stephane de Botton, Hartmut Döhner

Résultats de recherche: Contribution à un journal › Letter › Revue par des pairs

3 Citations (Scopus)

langue originale	Anglais
Pages (de - à)	2536-2537
Nombre de pages	2
journal	New England Journal of Medicine
Volume	386
Numéro de publication	26
Les DOIs	https://doi.org/10.1056/NEJMc2206489
état	Publié - 30 juin 2022

Accès au document

@article{5ba3a159129742179ac1d044315315a0,

title = "Ivosidenib and Azacitidine in IDH1-Mutated AML. Reply",

author = "Pau Montesinos and {de Botton}, Stephane and Hartmut D{\"o}hner",

year = "2022",

month = jun,

day = "30",

doi = "10.1056/NEJMc2206489",

language = "English",

volume = "386",

pages = "2536--2537",

journal = "New England Journal of Medicine",

issn = "0028-4793",

number = "26",

}

TY - JOUR

T1 - Ivosidenib and Azacitidine in IDH1-Mutated AML. Reply

AU - Montesinos, Pau

AU - de Botton, Stephane

AU - Döhner, Hartmut

PY - 2022/6/30

Y1 - 2022/6/30

UR - http://www.scopus.com/inward/record.url?scp=85133214236&partnerID=8YFLogxK

U2 - 10.1056/NEJMc2206489

DO - 10.1056/NEJMc2206489

M3 - Letter

C2 - 35767450

AN - SCOPUS:85133214236

SN - 0028-4793

VL - 386

SP - 2536

EP - 2537

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 26

ER -